Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Blood (2016) 127 (24): 3026–3034.

https://doi.org/10.1182/blood-2015-12-686550

Published: 2016

Includes: Supplemental data

Journal Articles

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma

Marco Fangazio, MD PhD, David Dominguez-Sola, MD PhD, Fabrizio Tabbò, MD, Davide Rossi, MD PhD, Julie Teruya-Feldstein, MD, Renzo Boldorini, MD, Gianluca Gaidano, MD PhD, Govind Bhagat, MD, Giorgio Inghirami, MD, Laura Pasqualucci, MD, Riccardo Dalla-Favera, MD

Blood (2014) 124 (21): 1692.

https://doi.org/10.1182/blood.V124.21.1692.1692

Published: 2014

Journal Articles

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

Blood (2012) 119 (12): 2854–2862.

https://doi.org/10.1182/blood-2011-12-395673

Published: 2012

Includes: Supplemental data

Journal Articles

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

Blood (2012) 119 (2): 521–529.

https://doi.org/10.1182/blood-2011-09-379966

Published: 2012

Includes: Supplemental data

Journal Articles

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

Blood (2011) 118 (26): 6904–6908.

https://doi.org/10.1182/blood-2011-08-373159

Published: 2011

Includes: Supplemental data

Journal Articles

Mutations of NOTCH1 Are An Independent Predictor of Survival in Chronic Lymphocytic Leukemia

Blood (2011) 118 (21): 283.

https://doi.org/10.1182/blood.V118.21.283.283

Published: 2011

Journal Articles

Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcome

Blood (2011) 118 (21): 2845.

https://doi.org/10.1182/blood.V118.21.2845.2845

Published: 2011

Journal Articles

Alteration of BIRC3 and Multiple Other NF-κB Pathway Genes in Splenic Marginal Zone Lymphoma

Blood (2011) 118 (21): 264.

https://doi.org/10.1182/blood.V118.21.264.264

Published: 2011

Journal Articles

Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

Marco Fangazio, Silvia Rasi, Tiziana Vaisitti, Sara Monti, Stefania Cresta, Alessio Bruscaggin, Valeria Spina, Francesco Forconi, Sabina Chiaretti, Anna Guarini, Silvia Deaglio, Robin Foà, Gianluca Gaidano, Davide Rossi

Blood (2011) 118 (21): 466.

https://doi.org/10.1182/blood.V118.21.466.466

Published: 2011

Journal Articles

Mutations of the SF3B1 splicing Factor in Chronic Lymphocytic Leukemia: Association with Progression and Fludarabine-Refractoriness

Blood (2011) 118 (21): 464.

https://doi.org/10.1182/blood.V118.21.464.464

Published: 2011

Journal Articles

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

Blood (2011) 118 (18): 4930–4934.

https://doi.org/10.1182/blood-2011-06-359166

Published: 2011

Includes: Supplemental data

Journal Articles

The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

Blood (2011) 117 (8): 2405–2413.

https://doi.org/10.1182/blood-2010-07-296244

Published: 2011

Includes: Supplemental data

Journal Articles

The Genotype of MLH1 Is An Independent Predictor of Outcome In Diffuse Large B-Cell Lymphoma Treated with R-CHOP: a Training-Validation Study

Blood (2010) 116 (21): 992.

https://doi.org/10.1182/blood.V116.21.992.992

Published: 2010

Journal Articles

The NF-κB Pathway Is Targeted by Multiple Genetic Lesions In Splenic Marginal Zone Lymphoma

Davide Rossi, Daniela Capello, Silvia Rasi, Valeria Spina, Marco Fangazio, Riccardo Bruna, Silvia Franceschetti, Stefania Cresta, Luca Arcaini, Luca Baldini, Jean Soulier, Catherine Thieblemont, Roberto Marasca, Fabio Facchetti, Andrea Rinaldi, Francesco Bertoni, Gianluca Gaidano

Blood (2010) 116 (21): 4169.

https://doi.org/10.1182/blood.V116.21.4169.4169

Published: 2010

Journal Articles

Molecular History of Richter Syndrome: Origin From a Common Ancestor Cell Already Present at Chronic Lymphocytic Leukemia Diagnosis

Davide Rossi, Valeria Spina, Daniela Capello, Francesco Forconi, Maurizio Martini, Silvia Rasi, Marco Fangazio, Valter Gattei, Luigi M. Larocca, Francesco Bertoni, Gianluca Gaidano

Blood (2010) 116 (21): 2425.

https://doi.org/10.1182/blood.V116.21.2425.2425

Published: 2010

Journal Articles

Beta-2-Microglobulin Is An Independent Predictor of Progression in Asymptomatic Multiple Myeloma.

Davide Rossi, MD, Marco Fangazio, MD, Lorenzo De Paoli, MD, Valeria Pinto, MD, Paola Riccomagno, MD, Alessia Puma, MD, Antonio Ramponi, MD, Guido Monga, MD, Gianluca Gaidano, MD, PhD

Blood (2009) 114 (22): 1796.

https://doi.org/10.1182/blood.V114.22.1796.1796

Published: 2009

Journal Articles

Host Genetic Background and Risk of Richter Syndrome: The Genotype of LRP4 Is An Independent Predictor of Chronic Lymphocytic Leukemia Transformation to Aggressive Lymphoma.

Davide Rossi, MD, Silvia Rasi, PhD, Claudio Tripodo, MD, Francesco Forconi, MD, PhD, Luca Laurenti, MD, Alessio Bruscaggin, PhD, Marco Fangazio, MD, Alessia Puma, MD, Elisa Sozzi, BSci, Jeffrey T. Malik, MD, Josep F. Nomdedeu, MD, Roberto Marasca, MD, Valter Gattei, MD, Ken H. Young, MD, PhD, Stefano A. Pileri, MD, Francesco Lauria, MD, Fabio Malavasi, MD, PhD, Silvia Deaglio, MD, PhD, Gianluca Gaidano, MD, PhD

Blood (2009) 114 (22): 2340.

https://doi.org/10.1182/blood.V114.22.2340.2340

Published: 2009

Journal Articles

The Host Genetic Background of DNA Repair Mechanisms Represents An Independent Predictor of Progression and Survival in Diffuse Large B-Cell Lymphoma Treated with R-CHOP.

Davide Rossi, MD, Silvia Rasi, PhD, Alberto Fabbri, MD, Francesco Forconi, MD, PhD, Marco Fangazio, MD, Alessio Bruscaggin, PhD, Silvia Franceschetti, MD, Lorenzo De Paoli, MD, Alessia Puma, MD, Ricardo Bruna, MD, Annalisa Chiappella, MD, Enrico M. Pogliani, MD, Francesco Lauria, MD, Umberto Vitolo, MD, Gianluca Gaidano, MD, PhD

Blood (2009) 114 (22): 442.

https://doi.org/10.1182/blood.V114.22.442.442

Published: 2009

NARROW

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

Mutations of NOTCH1 Are An Independent Predictor of Survival in Chronic Lymphocytic Leukemia

Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcome

Alteration of BIRC3 and Multiple Other NF-κB Pathway Genes in Splenic Marginal Zone Lymphoma

Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

Mutations of the SF3B1 splicing Factor in Chronic Lymphocytic Leukemia: Association with Progression and Fludarabine-Refractoriness

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

The Genotype of MLH1 Is An Independent Predictor of Outcome In Diffuse Large B-Cell Lymphoma Treated with R-CHOP: a Training-Validation Study

The NF-κB Pathway Is Targeted by Multiple Genetic Lesions In Splenic Marginal Zone Lymphoma

Molecular History of Richter Syndrome: Origin From a Common Ancestor Cell Already Present at Chronic Lymphocytic Leukemia Diagnosis

Beta-2-Microglobulin Is An Independent Predictor of Progression in Asymptomatic Multiple Myeloma.

Host Genetic Background and Risk of Richter Syndrome: The Genotype of LRP4 Is An Independent Predictor of Chronic Lymphocytic Leukemia Transformation to Aggressive Lymphoma.

The Host Genetic Background of DNA Repair Mechanisms Represents An Independent Predictor of Progression and Survival in Diffuse Large B-Cell Lymphoma Treated with R-CHOP.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only